Cancer treatment modality trang 1 tải miễn phí từ tailieunhanh

"Cancer treatment modality" trang 1 - tải miễn phí từ tailieunhanh

Longitudinal autoantibody responses against tumor-associated antigens decrease in breast cancer patients according to treatment modality

Longitudinal autoantibody responses against tumor-associated antigens decrease in breast cancer patients according to treatment modality

9 36 1

Identification of CEACAM5 as a stemness-related inhibitory immune checkpoint in pancreatic cancer

Identification of CEACAM5 as a stemness-related inhibitory immune checkpoint in pancreatic cancer

14 4 1

Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses

Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses

11 44 1

Under-treatment of elderly patients with ovarian cancer: A population based study

Under-treatment of elderly patients with ovarian cancer: A population based study

10 75 1

báo cáo khoa học:

báo cáo khoa học: " Multi-modality curative treatment of salivary gland cancer liver metastases with drug-eluting bead "

6 59 0

Clinical outcomes and prognostic factors of cyberknife stereotactic body radiation therapy for unresectable hepatocellular carcinoma

Clinical outcomes and prognostic factors of cyberknife stereotactic body radiation therapy for unresectable hepatocellular carcinoma

10 48 1

The clinical features and treatment modality of esophageal neuroendocrine tumors: A multicenter study in Korea

The clinical features and treatment modality of esophageal neuroendocrine tumors: A multicenter study in Korea

7 30 1

Cytoreductive surgery and Hyperthermic intra-operative peritoneal chemotherapy with Cisplatin for gastric peritoneal Carcinomatosis Monocentric phase-2 nonrandomized prospective clinical trial

Cytoreductive surgery and Hyperthermic intra-operative peritoneal chemotherapy with Cisplatin for gastric peritoneal Carcinomatosis Monocentric phase-2 nonrandomized prospective clinical trial

7 73 1

Risk factors affecting prognosis in metachronous liver metastases from WHO classification G1 and G2 gastroenteropancreatic neuroendocrine tumors after initial R0 surgical resection

Risk factors affecting prognosis in metachronous liver metastases from WHO classification G1 and G2 gastroenteropancreatic neuroendocrine tumors after initial R0 surgical resection

9 50 1